Drashtri Desai. (2017). Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC).
Lua i Stíl Chicago (17ú heag.)Drashtri Desai. Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC). 2017.
Lua MLA (9ú heag.)Drashtri Desai. Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC). 2017.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.